Precision Medicine for Autoimmunity – Mechanism of Action for CAAR T cell Therapy and Applications to B Cell-Mediated Autoimmune Diseases

Time: 11:30 am
day: Day One


  • Review mechanism of action for the CAAR T platform that is designed to recognize and eliminate only the B cells that cause the autoimmune disease in patients
  • Discuss progress in DesCAARTes trial of DSG3-CAART and preclinical development for select pipeline programs
  • Share rationale for indication prioritization and along with preclinical development path for new product candidates